X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10713) 10713
Book Chapter (70) 70
Dissertation (38) 38
Magazine Article (10) 10
Book / eBook (9) 9
Publication (9) 9
Newsletter (6) 6
Government Document (5) 5
Streaming Video (3) 3
Web Resource (3) 3
Newspaper Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8977) 8977
science & technology (8637) 8637
life sciences & biomedicine (8192) 8192
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4150) 4150
oncology (3929) 3929
hematology (3706) 3706
imatinib mesylate (3320) 3320
chronic myeloid leukemia (2986) 2986
male (2837) 2837
female (2776) 2776
leukemia, myelogenous, chronic, bcr-abl positive - genetics (2674) 2674
benzamides (2667) 2667
animals (2487) 2487
middle aged (2233) 2233
fusion proteins, bcr-abl - genetics (2190) 2190
adult (2160) 2160
pyrimidines - therapeutic use (2138) 2138
antineoplastic agents - therapeutic use (2097) 2097
leukemia (2022) 2022
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1969) 1969
hemic and lymphatic diseases (1825) 1825
piperazines - therapeutic use (1785) 1785
protein kinase inhibitors - therapeutic use (1678) 1678
mice (1658) 1658
aged (1650) 1650
imatinib (1527) 1527
pyrimidines - pharmacology (1350) 1350
protein-tyrosine kinases - antagonists & inhibitors (1322) 1322
treatment outcome (1242) 1242
fusion proteins, bcr-abl - metabolism (1234) 1234
cell biology (1232) 1232
biochemistry & molecular biology (1222) 1222
tyrosine (1180) 1180
cancer (1162) 1162
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (1146) 1146
piperazines - pharmacology (1133) 1133
mutation (1129) 1129
bcr-abl (1126) 1126
research (1126) 1126
antineoplastic agents - pharmacology (1083) 1083
phosphorylation (1025) 1025
protein kinase inhibitors - pharmacology (964) 964
cell line, tumor (911) 911
apoptosis (902) 902
dasatinib (887) 887
abridged index medicus (879) 879
care and treatment (879) 879
drug resistance, neoplasm (878) 878
genetic aspects (857) 857
signal transduction (851) 851
proto-oncogene proteins c-abl - metabolism (850) 850
kinases (834) 834
philadelphia chromosome (833) 833
cml (826) 826
fusion proteins, bcr-abl - antagonists & inhibitors (815) 815
adolescent (794) 794
k562 cells (785) 785
apoptosis - drug effects (744) 744
analysis (739) 739
young adult (708) 708
leukemia, myelogenous, chronic, bcr-abl positive - therapy (697) 697
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (689) 689
pyrimidines - adverse effects (669) 669
prognosis (668) 668
hematology, oncology and palliative medicine (667) 667
pyrimidines - administration & dosage (660) 660
aged, 80 and over (637) 637
proteins (635) 635
protein-tyrosine kinases - metabolism (617) 617
neoplasms (610) 610
antineoplastic agents - adverse effects (597) 597
pharmacology & pharmacy (592) 592
stem cells (582) 582
antineoplastic agents (574) 574
cell line (567) 567
health aspects (564) 564
gene expression (558) 558
drug therapy (555) 555
myeloid leukemia (548) 548
protein-tyrosine kinase (541) 541
drug resistance, neoplasm - genetics (532) 532
medicine & public health (524) 524
tumor cells, cultured (523) 523
piperazines - administration & dosage (515) 515
bcr protein (513) 513
genetics & heredity (503) 503
antimitotic agents (496) 496
chronic myelogenous leukemia (488) 488
drug resistance (488) 488
molecular sequence data (482) 482
leukemia, myelogenous, chronic, bcr-abl positive - enzymology (481) 481
proto-oncogene proteins c-abl - genetics (474) 474
antineoplastic agents - administration & dosage (469) 469
piperazines - adverse effects (464) 464
leukemia, myelogenous, chronic, bcr-abl positive - mortality (457) 457
protein kinase inhibitors - adverse effects (454) 454
cell proliferation - drug effects (448) 448
protein-tyrosine kinases - genetics (444) 444
medicine, research & experimental (442) 442
nilotinib (438) 438
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10468) 10468
Chinese (186) 186
Japanese (130) 130
French (69) 69
German (45) 45
Portuguese (36) 36
Spanish (26) 26
Polish (20) 20
Russian (17) 17
Czech (16) 16
Hungarian (14) 14
Italian (8) 8
Danish (7) 7
Korean (5) 5
Norwegian (3) 3
Ukrainian (3) 3
Dutch (2) 2
Finnish (2) 2
Hebrew (2) 2
Swedish (2) 2
Turkish (2) 2
Croatian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell (Cambridge), ISSN 0092-8674, 2003, Volume 112, Issue 6, pp. 859 - 871
Journal Article
Blood, ISSN 1528-0020, 03/2013, Volume 121, Issue 10, pp. 1824 - 1838
Journal Article
Biochemical journal, ISSN 1470-8728, 05/2009, Volume 420, Issue 3, pp. 345 - 361
RTKs (receptor tyrosine kinases) play important roles in cellular proliferation and differentiation... 
Extracellular-signal-regulated kinase (ERK) | Pleiotrophin | Anaplastic large cell lymphoma (ALCL) | Neuroblastoma | Non-small cell lung cancer (NSLCL) | Midkine | Anaplastic lymphoma kinase (ALK) | Inflammatory myofibroblastic tumour (IMT) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Neuroblastoma - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases | Protein-Tyrosine Kinases - genetics | Models, Biological | Oncogene Proteins, Fusion - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Neuroblastoma - metabolism | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Neuroblastoma - pathology | Lymphoma, Large-Cell, Anaplastic - genetics | Index Medicus | ALK, anaplastic lymphoma kinase | LTK, leucocyte tyrosine kinase | MUC-1, mucin-1 | IRS-1, IR substrate-1 | PTN, pleiotrophin | TGFβ, transforming growth factor β | neuroblastoma | extracellular-signal-regulated kinase (ERK) | pleiotrophin | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | Shc, Src homology and collagen homology | TPM, tropomyosin | IMP cyclohydrolase | MK, midkine | MYH9, non-muscle myosin heavy chain | MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu | NPM, nucleophosmin | mTOR, mammalian target of rapamycin | NIPA, nuclear interacting partner of ALK | RPTP, receptor protein tyrosine phosphatase | inflammatory myofibroblastic tumour (IMT) | DLBCL, diffuse large B-cell lymphoma | FOXO3a, forkhead box O 3a | NF-κB, nuclear factor κB | Shp1, SH2 domain-containing phosphatase 1 | RANBP2, Ran-binding protein 2 | ALCL, anaplastic large cell lymphoma | Dpp, decapentaplegic | FRS2, fibroblast growth factor receptor substrate 2 | LDLa, low-density lipoprotein class A | EGFR, epidermal growth factor receptor | SEC31L1, SEC31 homologue A | GIST, gastrointestinal stromal tumour | RTK, receptor tyrosine kinase | SH2, Src homology 2 | TFG, TRK-fused gene | ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase | midkine | CLTC, clathrin heavy chain | anaplastic large cell lymphoma (ALCL) | MAPK, mitogen-activated protein kinase | Hen-1, hesitation-1 | MEK, MAPK | PI3K, phosphoinositide 3-kinase | HEK, human embryonic kidney | SCD-2, suppressor of constitutive dauer 2 | Review | EBPβ, CCAAT | CARS, cysteinyl-tRNA synthetase | JNK, c-Jun N-terminal kinase | ERK kinase | Grb2, growthfactor-receptor-bound protein 2 | SCC, squamous cell carcinoma | EML4, echinoderm microtubule-associated protein like 4 | SHH, sonic hedghog | BCR-Abl, breakpoint cluster region-Abl | IR, insulin receptor | ALO17, ALK lymphoma oligomerization partner on chromosome 17 | enhancer-binding protein β | PLCγ, phospholipase Cγ | NSCLC, non-small cell lung cancer | UCN-01, unco-ordinated 1 | non-small cell lung cancer (NSLCL) | Cdc42, cell division cycle 42 | STAT, signal transducer and activator of transcription | anaplastic lymphoma kinase (ALK) | DRG, dorsal root ganglia | MSN, moesin | dALK, Drosophila ALK | IL-3, interleukin-3 | CNS, central nervous system | JAK, Janus kinase | CML, chronic myeloid leukaemia | Jeb, jelly belly | IMT, inflammatory myofibroblastic tumour
Journal Article